Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
44.97
-3.38 (-6.99%)
Jul 10, 2026, 2:50 PM EDT - Market open
Edgewise Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $51 | Buy | Initiates | $51 | +13.41% | Jul 9, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $41 → $51 | Buy | Maintains | $41 → $51 | +13.41% | Jul 6, 2026 |
| Wedbush | Wedbush | Buy Maintains $52 | Buy | Maintains | $52 | +15.63% | Jun 17, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 17, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $48 → $59 | Buy | Reiterates | $48 → $59 | +31.20% | Jun 17, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Reiterates $20 → $32 | Hold | Reiterates | $20 → $32 | -28.84% | Jun 17, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $50 → $52 | Buy | Reiterates | $50 → $52 | +15.63% | Jun 16, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $45 | Buy | Maintains | $45 | +0.07% | Jun 16, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.